Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Bristol-Myers to invest in Compugen, collaborate in clinical trials


Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors. (Reuters Science) More More

Similar stories

After Reaching Milestone, Is Compugen LTD. – Ordinary Shares (NASDAQ:CGEN)'s Short Interest Revealing ...

  1. After Reaching Milestone, Is Compugen LTD. – Ordinary Shares (NASDAQ:CGEN)'s Short Interest Revealing ...  Thorold News
  2. Full coverage

Posted on 17 October 2018 | 11:28 am | Google News

Compugen (NASDAQ:CGEN) and Agenus (AGEN) Head-To-Head Survey

  1. Compugen (NASDAQ:CGEN) and Agenus (AGEN) Head-To-Head Survey  Fairfield Current
  2. Full coverage

Posted on 17 October 2018 | 12:35 am | Google News

Analysts See $-0.19 EPS for Compugen Ltd. (CGEN)

  1. Analysts See $-0.19 EPS for Compugen Ltd. (CGEN)  The Cardinal Weekly (press release)
  2. Full coverage

Posted on 16 October 2018 | 8:01 pm | Google News

BMS and Compugen join forces on solid tumour clinical trials

  1. BMS and Compugen join forces on solid tumour clinical trials  Pharmafield (press release)
  2. Full coverage

Posted on 16 October 2018 | 4:17 am | Google News

BMS invests in Compugen, grants access to Opdivo for combo trial

  1. BMS invests in Compugen, grants access to Opdivo for combo trial  BioProcess Insider
  2. Full coverage

Posted on 15 October 2018 | 8:55 pm | Google News

EPS for Compugen Ltd. (CGEN) Expected At $-0.19

  1. EPS for Compugen Ltd. (CGEN) Expected At $-0.19  MoneyMakingArticles
  2. Full coverage

Posted on 15 October 2018 | 3:37 pm | Google News

Copyright © 2018 LastMinuteStuff.com
Contact info